Aspartame is considered safe within daily limits, yet researchers are studying whether it may affect tardive dyskinesia. Here’s what early findings suggest.
Aspartame is one of the most commonly used artificial sweeteners, found in diet sodas, sugar-free gum, and low-calorie foods. While regulatory agencies around the world consider it safe when consumed within daily limits, some researchers and clinicians have raised concerns about its potential neurological effects — particularly in vulnerable populations.
Tardive dyskinesia, a movement disorder that affects some people who take antipsychotics, has been linked to aspartame in preliminary findings. Could there be a connection? Here are five key ways aspartame might influence the onset or symptoms of tardive dyskinesia.
What Happens in Your Body After You Eat or Drink Aspartame?
Aspartame is a super-sweet sugar substitute — about 200 times sweeter than table sugar — made from two amino acids found naturally in many foods: phenylalanine and aspartic acid. According to a systematic review, your digestive system breaks it down quickly into these same components, along with a small amount of methanol, which is also naturally present in some fruits and vegetables.
Researchers note that high levels of phenylalanine may influence dopamine and serotonin, two brain chemicals that help regulate movement and mood. That’s one reason scientists continue to look at how aspartame might affect the brain over time, especially in people who may be more sensitive.
Because phenylalanine can be risky for people with a rare genetic condition called phenylketonuria (PKU), both European and U.S. regulations require foods containing aspartame to carry a clear label indicating it as a source of phenylalanine.
Health agencies, including the U.S. Food and Drug Administration (FDA), consider aspartame safe for the general population when used as approved. For example, in baked goods, it can’t exceed 0.5 percent of the recipe, and the U.S. daily limit is 50 milligrams per kilogram of body weight. People with PKU, however, should avoid it altogether.
Even with these safeguards, scientists are still exploring potential long-term neurological effects in certain at-risk groups. So while aspartame is widely regarded as safe for most people, the research — and the conversation — continues.
Elevated Phenylalanine Levels May Increase the Risk of Tardive Dyskinesia
One of aspartame’s main building blocks — phenylalanine — has drawn attention for a possible connection to tardive dyskinesia, a movement disorder that can occur in people taking antipsychotic medications.
Decades ago, research hypothesized that higher phenylalanine levels might make tardive dyskinesia symptoms worse in people using antipsychotics. More recently, researchers have found deeper clues. In a study published in February 2025, people with schizophrenia who developed tardive dyskinesia showed altered phenylalanine metabolism compared with those who did not.
The authors even suggested that phenylalanine might someday help doctors identify tardive dyskinesia earlier as a potential biomarker (a measurable sign of disease).
Why does phenylalanine matter so much? It ultimately comes down to how this amino acid affects dopamine, which plays a crucial role in controlling movement. The body normally uses phenylalanine to help make dopamine. But if phenylalanine builds up, it can disrupt that process and lower dopamine production.
Because antipsychotic medications already make the brain’s dopamine receptors more sensitive, even small changes in dopamine — whether too much or too little — can increase the risk of triggering or worsening tardive dyskinesia symptoms.
This research does not prove that aspartame causes tardive dyskinesia, but it does raise important questions for anyone taking medications that affect dopamine — including many antipsychotics. These medications are widely used to treat serious mental health conditions, including bipolar disorder, which is why this research has special relevance.
If you’re concerned about your diet or your risk for tardive dyskinesia, consider discussing aspartame use with your healthcare provider.
Aspartame Blocks Some Neurotransmitters
Aspartame is metabolized into 50 percent phenylalanine, 40 percent aspartic acid, and 10 percent methanol after ingestion. Research suggests that the top two metabolites, phenylalanine and aspartic acid, can cross the blood-brain barrier. Once it reaches the brain, phenylalanine can affect the production or release of certain neurotransmitters, such as dopamine, norepinephrine, or serotonin.
In addition, some preclinical animal studies suggest that aspartic acid has been linked to the degeneration of neurons, nerve cells that transmit signals throughout the body, and astrocytes, central nervous system cells that help protect neurons from damage.
These neurotransmitters and neurons play a crucial role in thinking, memory, and mood. By disrupting neurons and their signaling pathways, the researchers say, aspartame might contribute to a wide range of neurophysiological symptoms, such as:
Aspartame’s impacts on neurological signaling could be relevant to tardive dyskinesia because it could affect brain chemistry that is already out of balance. Tardive dyskinesia is itself linked with neuronal damage and altered brain signaling, research shows.
Long-Term Dopamine Changes May Cause Tardive Dyskinesia
Tardive dyskinesia usually stems from long-term use of antipsychotic medications. These drugs block dopamine and sensitize dopamine receptors over time. Within months or years of using antipsychotics, the brain responds to this dopamine blockade by making its dopamine receptors extra sensitive, according to Cleveland Clinic.
Experts still don’t know the exact cause of tardive dyskinesia, but the leading theory is called the dopamine hypersensitivity hypothesis. In simple terms, the brain adapts to dopamine-blocking drugs by producing more D2 dopamine receptors, especially in a movement-control area of the brain known as the striatum.
At first, this change increases “brake signals” from the striatum to the thalamus, the part of the brain that coordinates motor activity. Over the long term, though, those braking signals weaken, allowing excess movement activity to break through — which can show up as the involuntary, repetitive motions seen in tardive dyskinesia.
Researchers are also exploring whether aspartame might influence this process. Phenylalanine, one of aspartame’s components, affects dopamine release and could interact with these same pathways. More studies are needed to clarify if — and how — it contributes.
Aspartame May Increase Oxidative Stress and Neuroinflammation
Emerging research is examining whether aspartame may contribute to oxidative stress and neuroinflammation, both linked to cognitive decline, neurodegenerative disorders, and tardive dyskinesia. It’s important to emphasize that the research is mostly preclinical (animal and cell studies), and evidence in humans remains limited.
Research in both animals and humans has linked aspartame to oxidative stress, a type of cell damage, and to injury of brain cells (neurons). One earlier study found that when animals consumed large amounts of aspartame, the balance of protective antioxidants in the brain shifted — possibly because of higher levels of methanol, a natural byproduct of aspartame. As oxidative stress builds, it can harm the proteins, fats, and DNA inside neurons, sometimes leading to their death.
Other mouse studies point to another concern: neuroinflammation, or inflammation in the brain. Scientists suspect that methanol and aspartic acid — both breakdown products of aspartame — can overstimulate microglia, the brain’s cleanup cells. When these cells stay overactive, they may begin to damage healthy neurons instead of protecting them.
The neuron-damaging effects of oxidative stress and neuroinflammation could be particularly relevant for tardive dyskinesia. According to a theory called the “reactive oxygen species hypothesis,” the neurotoxic free radicals produced by antipsychotic medications may contribute to tardive dyskinesia.
Research indicates that another theory says neuroinflammation in the striatum and another brain region (the lateral habenula) might also play a role in tardive dyskinesia. Many of the disorders treated by antipsychotics are already marked by neuroinflammation, and medications might add to it by raising dopamine levels or harming liver cells.
However, more research is needed to draw firm conclusions about the role of oxidative stress and neuroinflammation in tardive dyskinesia.
Key Takeaways
- Aspartame is considered safe for most people, but its long-term effects on the brain — especially in higher-risk groups — are still being studied.
- Because aspartame breaks down into phenylalanine, a higher intake could matter for those at risk of tardive dyskinesia or for people who are taking dopamine-blocking medication.
- Aspartame’s byproducts may affect neurotransmitters and the health of neurons and other brain cells, potentially affecting the onset of tardive dyskinesia or its symptoms.
- Some early preclinical research linked aspartame to oxidative stress and neuroinflammation, two mechanisms that are also explored in tardive dyskinesia.
- Tardive dyskinesia is primarily linked to long-term antipsychotic use and dopamine receptor changes; while aspartame is being studied as a possible factor, evidence remains preliminary, and no causal link has been established.
Editorial Sources and Fact Checking
- Ruiz-Ojeda F et al. Effects of Sweeteners on the Gut Microbiota: A Review of Experimental Studies and Clinical Trials. Advances in Nutrition. February 5, 2019.
- Shaher SA et al. Aspartame Safety as a Food Sweetener and Related Health Hazards. Nutrients. August 18, 2023.
- Code of Federal Regulations: Title 21, Chapter I, Subchapter B, Part 172, Subpart 1. National Archives and Records Administration.
- Aspartame and Other Sweeteners in Food. U.S. Food and Drug Administration. February 27, 2025.
- Czarnecka K et al. Aspartame —True or False? Narrative Review of Safety Analysis of General Use in Products. Nutrients. June 7, 2021.
- Mosnik M et al. Tardive Dyskinesia Exacerbated After Ingestion of Phenylalanine by Schizophrenic Patients. Neuropsychopharmacology. February 1997.
- Lu C et al. Plasma Metabolic Characteristics and Potential Biomarker Combinations in Schizophrenia Patients With Tardive Dyskinesia. Schizophrenia Bulletin. February 21, 2025.
- Choudhary A et al. Neurophysiological Symptoms and Aspartame: What Is the Connection? Nutritional Neuroscience. February 15, 2017.
- Ludwig P et al. Neuroanatomy, Neurons. StatPearls. July 24, 2023.
- Verkhratsky A et al. Astrocytes in Human Central Nervous System Diseases: A Frontier for New Therapies. Signal Transduction and Targeted Therapy. October 13, 2023.
- Takeuchi H et al. Pathophysiology, Prognosis and Treatment of Tardive Dyskinesia. Therapeutic Advances in Psychopharmacology. October 21, 2022.
- Tardive Dyskinesia: Symptoms, Causes, Diagnosis, Treatment, and Management. Cleveland Clinic. July 10, 2024.
- Gephstein S et al. Dopamine Function and the Efficiency of Human Movement. Journal of Cognitive Neuroscience. March 23, 2016.
- Young C et al. Neuroanatomy, Basal Ganglia. StatPearls. July 24, 2023.
- Thalamus. Cleveland Clinic. March 30, 2022.
- Fogel M et al. Aspartame and Its Potential Neurocognitive Effects in Humans. Nutrition Reviews. July 3, 2025.
- Iyyaswamy A et al. Effect of Chronic Exposure to Aspartame on Oxidative Stress in Brain Discrete Regions of Albino Rats. Journal of Biosciences. August 3, 2012.
- Trofin D et al. Oxidative Stress in Brain Function. Antioxidants. February 28, 2025.
- Dar W et al. Aspartame-Induced Cognitive Dysfunction: Unveiling Role of Microglia-Mediated Neuroinflammation and Molecular Remediation. International Immunopharmacology. June 30, 2024.
- Colonna M et al. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annual Review of Immunology. February 9, 2017
- Loonen A et al. Putative Role of Immune Reactions in the Mechanism of Tardive Dyskinesia. Brain, Behavior and Immunity Health. September 23, 2023.
- Vasan S et al. Tardive Dyskinesia. StatPearls. April 24, 2023.